NervGen Pharma Corp. (NGENF)
OTCMKTS
· Delayed Price · Currency is USD
2.590
+0.020 (0.76%)
May 14, 2025, 3:52 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $184.94 million as of May 14, 2025. Its market cap has increased by 75.25% in one year.
Market Cap
184.94M
Enterprise Value
172.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.59
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 184.94M, an increase of 392.52%. That is a compound annual growth rate of 29.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 712.65M |
| Tian'an Technology Group | 591.73M |
| CytoDyn | 510.85M |
| Glass House Brands | 496.70M |
| Elite Pharmaceuticals | 458.29M |
| Northwest Biotherapeutics | 411.95M |